Exelixis Inc. (EXEL)
Here's Why Exelixis (EXEL) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
EXEL or ARGX: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Exelixis (EXEL) and argenex SE (ARGX). But which of these two companies is the best option for those looking for undervalued stocks?
Why Is Exelixis (EXEL) Down 7.2% Since Last Earnings Report?
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock?
3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)
Exelixis (EXEL) possesses solid growth attributes, which could help it handily outperform the market.
Are You Looking for a Top Momentum Pick? Why Exelixis (EXEL) is a Great Choice
Does Exelixis (EXEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
Top-ranked stocks Urban Outfitters (URBN), Tenet Healthcare (THC), Five9 (FIVN), Marqeta (MQ) and Exelixis (EXEL) are likely to beat on the bottom line in their upcoming releases.
Why Exelixis (EXEL) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Exelixis (EXEL) Upgraded to Buy: What Does It Mean for the Stock?
Exelixis (EXEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Earnings Estimates Moving Higher for Exelixis (EXEL): Time to Buy?
Exelixis (EXEL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
3 Reasons Why Growth Investors Shouldn't Overlook Exelixis (EXEL)
Exelixis (EXEL) possesses solid growth attributes, which could help it handily outperform the market.
EXEL vs. ARGX: Which Stock Is the Better Value Option?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Exelixis (EXEL) and argenex SE (ARGX). But which of these two stocks offers value investors a better bang for their buck right now?
EXEL Reports Superior Efficacy Data From Kidney Cancer Study Cohort
Exelixis' zanzalintinib/Opdivo combo shows superior efficacy for treating kidney cancer in an expansion cohort of the phase Ib/II STELLAR-002 study.
